The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug – STAT

September 7, 2017 by  
Filed under Alzheimers News

Sponsored By

STAT
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer's drug
STAT
Medivation, a California startup, was developing a treatment for Alzheimer's disease, and pivotal results from a major clinical trial were finally available. An earlier study, conducted in Russia, had generated what Alzheimer's experts hailed as the

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*